BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34333285)

  • 21. Maize extract rich in ferulic acid and anthocyanins prevents high-fat-induced obesity in mice by modulating SIRT1, AMPK and IL-6 associated metabolic and inflammatory pathways.
    Luna-Vital D; Luzardo-Ocampo I; Cuellar-Nuñez ML; Loarca-Piña G; Gonzalez de Mejia E
    J Nutr Biochem; 2020 May; 79():108343. PubMed ID: 32007662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation of the Flavonoid Myricitrin Attenuates the Adverse Metabolic Effects of Long-Term Consumption of a High-Fat Diet in Mice.
    Kim YJ; Kim SR; Kim DY; Woo JT; Kwon EY; Han Y; Choi MS; Jung UJ
    J Med Food; 2019 Nov; 22(11):1151-1158. PubMed ID: 31549892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Gingerol Ameliorates Adiposity and Inflammation in Adipose Tissue in High Fat Diet-Induced Obese Mice: Association with Regulating of Adipokines.
    Hong KH; Um MY; Ahn J; Ha TY
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    Schoemaker MH; Kleemann R; Morrison MC; Verheij J; Salic K; van Tol EAF; Kooistra T; Wielinga PY
    PLoS One; 2017; 12(7):e0180648. PubMed ID: 28678821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.
    Han Y; Han HJ; Kim AH; Choi JY; Cho SJ; Park YB; Jung UJ; Choi MS
    Mol Nutr Food Res; 2016 Jul; 60(7):1695-706. PubMed ID: 26920079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice.
    Cruz MM; Simão JJ; de Sá RDCC; Farias TSM; da Silva VS; Abdala F; Antraco VJ; Armelin-Correa L; Alonso-Vale MIC
    Front Endocrinol (Lausanne); 2020; 11():537061. PubMed ID: 33117273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development.
    Iñiguez M; Pérez-Matute P; Villanueva-Millán MJ; Recio-Fernández E; Roncero-Ramos I; Pérez-Clavijo M; Oteo JA
    J Physiol Biochem; 2018 Nov; 74(4):635-646. PubMed ID: 30288689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice.
    Zeng Q; Zhao L; Meng C; Zhao X; Liu Y; Shi R; Han X; Wang T; Li J
    Biomed Pharmacother; 2020 Nov; 131():110792. PubMed ID: 33152949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
    Yao Y
    Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice.
    Lee HS; Nam Y; Chung YH; Kim HR; Park ES; Chung SJ; Kim JH; Sohn UD; Kim HC; Oh KW; Jeong JH
    Life Sci; 2014 Nov; 118(1):7-14. PubMed ID: 25445436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced obese mice.
    Kim MS; Kim B; Park H; Ji Y; Holzapfel W; Kim DY; Hyun CK
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1744-1751. PubMed ID: 29222051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
    Bartelt A; Orlando P; Mele C; Ligresti A; Toedter K; Scheja L; Heeren J; Di Marzo V
    Diabetologia; 2011 Nov; 54(11):2900-10. PubMed ID: 21847582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
    PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
    Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
    Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice.
    Chiang H; Lee JC; Huang HC; Huang H; Liu HK; Huang C
    Br J Pharmacol; 2020 Jan; 177(2):239-253. PubMed ID: 31497874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.